Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.

Details

Serval ID
serval:BIB_0A745D9C879D
Type
Article: article from journal or magazin.
Collection
Publications
Title
Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Journal
European Journal of Cancer
Author(s)
Malouf G.G., Casiraghi O., Deutsch E., Guigay J., Temam S., Bourhis J.
ISSN
1879-0852 (Electronic)
ISSN-L
0959-8049
Publication state
Published
Issued date
2013
Volume
49
Number
6
Pages
1324-1334
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish
Abstract
PURPOSE: Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described.
PATIENTS AND METHODS: Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009.
RESULTS: Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade>III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p=0.02), have frequent lymph node involvement (p=0.009) and are more often unresectable (p=0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n=4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n=10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively.
CONCLUSION: Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.
Keywords
Adolescent, Adult, Aged, Chemotherapy, Adjuvant, Child, Chromogranins/metabolism, Combined Modality Therapy, Esthesioneuroblastoma, Olfactory/pathology, Esthesioneuroblastoma, Olfactory/surgery, Female, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Multivariate Analysis, Nasal Cavity/metabolism, Nasal Cavity/pathology, Neoplasm Grading, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasm Staging, Nose Neoplasms/pathology, Nose Neoplasms/surgery, Prognosis, Radiotherapy, Adjuvant, Synaptophysin/metabolism, Treatment Outcome
Pubmed
Web of science
Create date
10/03/2014 15:25
Last modification date
20/08/2019 13:32
Usage data